Events
This was 1 year ago
Herman Teirlinckgebouw, Havenlaan 88, 1000 Brussel
The Strategic Goods Control department is again organising training courses so you can become acquainted with the subject matter.
There will be a physical session on basic dual use training on 18 June 2025.
This session is part of a series of 3 sessions. The other two taking place on 25 February (online) and 20 November (online).
More info on the website of dCSG.
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
The European Commission organises an online information session on the Horizon Europe call for proposals on the EU AI Media Platform (HORIZON-BRIDGING-2027-01-09). The topic is about modular multilingual public-interest infrastructure for European news and audiovisual media. This online session is aimed at media organisations,...
Read moreThis workshop looks at how citizen-generated data on soil health can support policy and decision-making. It focuses on insights from the ECHO project, including potential end users of this data, its practical use, and the costs and value linked to collecting it. The discussion is set in the current EU soil policy context and also invites contributions from other Mission Soil projects.
Read moreThe fourth edition of the European Mission Soil Week is designed to bring together a wide range of stakeholders working on making our soils cleaner and healthier. The conference is organised by the European Commission's Directorate-General for Agriculture and Rural Development under the auspices of the Irish Presidency of the Council of the EU....
Read moreThe summit brings together industrial representatives, policymakers and startups to look at how AI can be applied in strategic sectors across Europe. It is designed to discuss AI uptake in areas such as healthcare, mobility, public administration, manufacturing and energy, with examples of European use cases and a virtual participation option.
Read moreTestimonial
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
